TSX Delisting Review – Prometic Life Sciences Inc. (PLI)

August 15, 2019
Issuer: Prometic Life Sciences Inc. (the "Company")
Securities: Common Shares
Symbol(s): PLI
Delisting Review Status: TSX has determined that the Company has regained compliance with the requirements for continued listing.
Additional Information: Please refer to TSX Bulletin #2019-0278 dated April 16, 2019.
TSX contact: Chris Birkett,
Toronto Stock Exchange